Loading…
Landy International, a Chinese drug manufacturer of over-the-counter hand sanitizers, violated Current Good Manufacturing Practice (CGMP) regulations by failing to adequately test batches for identity and strength of the active ingredient ethanol before release and distribution. This was a repeat violation from a previous January 2017 inspection, and the company's corrective response was deemed inadequate because it lacked sufficient detail, cited incorrect regulatory requirements, and failed to commit to a risk assessment of previously released products. The FDA found that the company's manufacturing methods, facilities, and controls did not conform to CGMP standards, rendering their drug products adulterated under federal law.